Page last updated: 2024-09-03

sdz 220-581 and dizocilpine maleate

sdz 220-581 has been researched along with dizocilpine maleate in 1 studies

Compound Research Comparison

Studies
(sdz 220-581)
Trials
(sdz 220-581)
Recent Studies (post-2010)
(sdz 220-581)
Studies
(dizocilpine maleate)
Trials
(dizocilpine maleate)
Recent Studies (post-2010) (dizocilpine maleate)
11057,74191,449

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McAllister, KH1

Other Studies

1 other study(ies) available for sdz 220-581 and dizocilpine maleate

ArticleYear
The competitive NMDA receptor antagonist SDZ 220-581 reverses haloperidol-induced catalepsy in rats.
    European journal of pharmacology, 1996, Oct-31, Volume: 314, Issue:3

    Topics: Animals; Antipsychotic Agents; Binding, Competitive; Biphenyl Compounds; Catalepsy; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Haloperidol; Male; Molecular Structure; Neuroprotective Agents; Propionates; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Statistics, Nonparametric; Structure-Activity Relationship

1996